The virus might be changing in ways that let it slip past immunity
In the laboratories of São Paulo's Butantan Institute, scientists have identified two previously unknown offshoots of the Delta variant circulating within the city's metropolitan region — a discovery that quietly raises one of the pandemic's most persistent anxieties: whether the virus, in its endless variation, might find ways around the immunity that vaccination has built. The findings, led by Sandra Coccuzzo and colleagues from twelve institutions, are preliminary and unreviewed, yet their emergence in a heavily vaccinated population lends them a weight that caution alone cannot fully dispel. Science responds as it must — with closer watching, wider sequencing, and a renewed argument for the tools that have, so far, kept the worst at bay.
- Two new Delta sublineages, derivatives of AY.43, have been detected in São Paulo's metropolitan area — a region where high vaccination coverage made their emergence unexpected and unsettling.
- The central fear is not yet about deadlier disease, but about immune escape: that these genetic mutations may allow the virus to sidestep the protection vaccines have conferred.
- Most of the sequenced samples traced back to Brazil itself, suggesting these variants likely arose domestically rather than crossing borders — raising questions about how far they may have already spread.
- Researchers are careful to note the findings are preprint and early-stage, with transmissibility and severity still unknown, urging measured concern rather than alarm.
- The Butantan team frames vaccination not as a failed shield but as the reason an exponential surge has not already occurred, calling for its expansion alongside intensified genomic surveillance.
- The study's breadth — twelve institutions including USP and Fiocruz — signals that Brazil's scientific community is treating variant monitoring as a collective and urgent responsibility.
Researchers at São Paulo's Butantan Institute announced the discovery of two previously unknown coronavirus lineages circulating in the city's metropolitan region. Both are descendants of the Delta variant — specifically offshoots of AY.43, one of roughly 120 known Delta subgroups — and their identification, led by Sandra Coccuzzo and a team spanning twelve institutions, was published as a preprint on MedRxiv, pending formal peer review.
What made the discovery particularly striking was where it happened. São Paulo's metropolitan area has seen substantial vaccine coverage, with much of the population having received two doses or the single-dose Johnson & Johnson shot. Yet these two new lineages appeared to be taking hold regardless. The scientists' primary concern was not that the variants were more transmissible or more severe — it is too early to know either — but that their mutations might allow the virus to evade vaccine-induced immunity. An emergence in a heavily vaccinated population made that possibility feel less abstract.
The team also noted that the vast majority of sequences they analyzed originated within Brazil, suggesting the sublineages likely developed domestically. How far beyond São Paulo they had spread remained unclear at the time of publication.
Still, the Butantan researchers were deliberate in framing their findings constructively. Vaccination, they argued, had already prevented what could have been a far more explosive spread of Delta through the population. The answer was not doubt in the vaccines, but deeper investment in two things: broader vaccination coverage, and robust genomic surveillance — the continuous sequencing of the virus as it circulates. The study, involving USP, Fiocruz, and ten other institutions, reinforced a lesson the pandemic has taught repeatedly: understanding what the virus is becoming, at the genetic level, is inseparable from the work of containing it.
Researchers at São Paulo's Butantan Institute announced this week that they had identified two previously unknown lineages of the coronavirus circulating through the metropolitan region. Both were descendants of the Delta variant, and their discovery raised an uncomfortable question: could these mutations slip past the protection that vaccines provide?
The two lineages are offshoots of AY.43, itself one of roughly 120 known subgroups within the Delta family. The work was led by Sandra Coccuzzo and her team, and the findings were posted as a preprint on MedrXiv—meaning they have not yet undergone formal peer review. Still, the timing and location of the discovery troubled the scientists involved. São Paulo's metropolitan area is not a place where the virus would be expected to find much room to spread. A substantial portion of the population there had already received two vaccine doses, or in some cases the single-dose Johnson & Johnson shot. Yet here were two new Delta lineages, apparently taking hold anyway.
The researchers were careful not to overstate what they knew. It remains too early, they said, to determine whether these particular mutations make the virus more transmissible or more lethal than earlier versions. The real concern was narrower and more specific: that the genetic changes might allow the virus to evade the immune response that vaccination had built up. The fact that the lineages had emerged in a heavily vaccinated area made that possibility feel less theoretical.
What struck the team most was the composition of their sample. The vast majority of the genetic sequences they analyzed came from Brazil itself, suggesting that these two sublineages had likely originated within the country rather than arriving from elsewhere. How widely they had spread beyond São Paulo, or even beyond the metropolitan area, remained unclear. The researchers had identified the variants, but the full picture of their circulation was still incomplete.
Yet the Butantan team was careful to place their findings in context. Vaccination, they emphasized, had already prevented what could have been an exponential surge in cases as Delta moved through the population. The solution was not to abandon vaccination but to expand it further. The real lesson, they argued, was the importance of genomic surveillance—the systematic sequencing and monitoring of the virus as it circulates. Only through that kind of continuous watchfulness could new variants be spotted early, before they became widespread problems. The study involved researchers from twelve institutions in total, including the University of São Paulo and Fiocruz, Brazil's federal research foundation. The work underscored a principle that had become clearer as the pandemic wore on: knowing what the virus was doing, at the genetic level, was as important as knowing how many people had fallen ill.
Citas Notables
The vast majority of sequences analyzed from the two lineages were Brazilian, suggesting these sublineages likely emerged in Brazil— Butantan research team
Genomic monitoring of the coronavirus remains essential for early identification of emerging variants— Butantan research team
La Conversación del Hearth Otra perspectiva de la historia
Why would scientists worry about a variant emerging in a place where most people are already vaccinated? Shouldn't vaccination make that less likely?
That's the unsettling part. It suggests the virus might be changing in ways that let it slip past immunity that worked against earlier versions. The vaccination rate is high, but if the virus is evolving to evade it, that's a different problem than simple transmission.
But they said it's too early to know if these lineages are actually more dangerous or more transmissible. So what exactly are they concerned about?
The escape potential. The genetic changes are there. Whether they actually translate into a real-world advantage for the virus—that takes time to measure. But you don't wait for certainty when you're tracking a virus. You flag it, you watch it, you prepare.
The study hasn't been peer-reviewed yet. Does that matter for how seriously we should take this?
It matters for confidence in the details, but not for the signal. Preprints are how scientists communicate urgently with each other. Peer review will come. What matters now is that multiple institutions saw the same thing and thought it worth publishing.
They said most of the sequences were Brazilian. Does that mean the virus originated here, or just that Brazil was better at detecting it?
Likely both. Brazil has genomic surveillance capacity, so they're catching variants. But the pattern suggests these lineages emerged and circulated here first, which is its own kind of information—it tells you where to watch next.
So what happens now?
More sequencing. More monitoring. The researchers made clear that this is exactly why you need continuous genetic surveillance. You spot the variant, you track its spread, you understand what it's doing. Then you adjust.